Performance evaluation of the point-of-care SAMBA II SARS-CoV-2 Test for detection of SARS-CoV-2
Detection Principle
NucleicAcid-Others
Target
ORF1ab and Nucleocapsid protein (region 2)
Testing Method Category
Other sequencing method(s)
Testing Method
SAMBA II SARS-CoV-2 Test for detection of SARS-CoV-2
Testing Method - Additional Info
Performance evaluation of the SAMBA II SARS-CoV-2 test detecxtion of SARS-CoV-2
Reported Performance
LOD: 250 cp/mL; Sensitivity: 98.9%; Specificity: 100%; PPV: 100%; NPV: 98.78%
Sample Size
172 clinical samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements